Last updated: February 11, 2026
Sponsor: University of Pennsylvania
Overall Status: Active - Recruiting
Phase
1
Condition
Seizure Disorders
Epilepsy
Treatment
Intracranial electroencephalography recordings
3T Magnetic Resonance Imaging
7T Magnetic Resonance Imaging
Clinical Study ID
NCT04649008
819126
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with medication-refractory epilepsy
Planned intracranial EEG (IEEG) placement
Hypothesized to have temporal lobe epilepsy
Exclusion
Exclusion Criteria:
- Contraindication to 3T MRI (e.g. metal implants or claustrophobia), clinicalfeatures that typically preclude the use of IEEG (e.g. pregnancy), priorintracranial surgery or device, and IEEG findings that are non-diagnostic (e.g.seizure onset zone(s) not identified)
Study Design
Total Participants: 290
Treatment Group(s): 3
Primary Treatment: Intracranial electroencephalography recordings
Phase: 1
Study Start date:
March 01, 2021
Estimated Completion Date:
February 28, 2027
Study Description
Connect with a study center
University of Pennsylvania
Philadelphia, Pennsylvania 19104
United StatesSite Not Available
University of Pennsylvania
Philadelphia 4560349, Pennsylvania 6254927 19104
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.